Michael Scolaro

Michael Scolaro

Nov 01, 2017

Group 6 Copy 21
0
    Please wait...

    About This Project

    We have invented a Nanocarrier that targets the Immune System to deliver Curcumin, an anti-inflammatory agent, to the brain for the treatment of neurodegenerative diseases, such as Chronic Traumatic Encephalopathy.

    Our preclinical study at Charles River Labs and the U. of Arizona, is being conducted to establish proof of effective nanocarrier delivery of Curcumin to the cells of the brain damaged by repeated traumatic athletic injuries to the head.

    Blast off!

    Browse Other Projects on Experiment

    Related Projects

    Can Data Management Tools Improve Research Efficiency and Reproducibility?

    Scientists are generating data at unprecedented rates, but our data management methods have yet to evolve accordingly...

    How does sleep deprivation impact problematic eating?

    Research studies have linked characteristics of eating disorders (e.g., binge eating, extreme dieting) with...

    Will This Mobile Resource Help Healthcare Professionals Prescribe Antidepressants?

    Understanding pharmacological agents is key to treatment selection. For the increasing involvement of primary...

    Backer Badge Funded